Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Levitan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Physiology. Endocrinology and Metabolism|February 2, 2017
Phenotyping of adipose, liver, and skeletal muscle insulin resistance and response to pioglitazone in spontaneously obese rhesus monkeysJin Shang, Stephen F Previs, Stacey Conarello, et al.
Journal of Cellular Physiology|March 25, 2010
Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cellsHong Lan, Ling Pang, Marsha M Smith, et al.
Journal of Parkinson'S Disease|April 25, 2022
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's DiseaseSusan J Lee, Peter M Shaw, Bob Thornton, et al.
International Journal of Alzheimer'S Disease|April 11, 2013
In Vivo Characterization of a Novel γ-Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side EffectsLynn A Hyde, Qi Zhang, Robert A Del Vecchio, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Molecular Neurodegeneration|May 20, 2017
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 miceNicholas B Hastings, Xiaohai Wang, Lixin Song, et al.
JAMA Oncology|March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialCharles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Physiology. Endocrinology and Metabolism|February 2, 2017
Phenotyping of adipose, liver, and skeletal muscle insulin resistance and response to pioglitazone in spontaneously obese rhesus monkeysJin Shang, Stephen F Previs, Stacey Conarello, et al.
Journal of Cellular Physiology|March 25, 2010
Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cellsHong Lan, Ling Pang, Marsha M Smith, et al.
Journal of Parkinson'S Disease|April 25, 2022
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's DiseaseSusan J Lee, Peter M Shaw, Bob Thornton, et al.
International Journal of Alzheimer'S Disease|April 11, 2013
In Vivo Characterization of a Novel γ-Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side EffectsLynn A Hyde, Qi Zhang, Robert A Del Vecchio, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Molecular Neurodegeneration|May 20, 2017
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 miceNicholas B Hastings, Xiaohai Wang, Lixin Song, et al.
JAMA Oncology|March 16, 2018
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialCharles S Fuchs, Toshihiko Doi, Raymond W Jang, et al.
Pageof 2